Intuitive Surgical (NASDAQ:ISRG) EVP Sells $16,616.58 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Mark Brosius sold 46 shares of the firm's stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $361.23, for a total value of $16,616.58. Following the completion of the transaction, the executive vice president owned 835 shares in the company, valued at approximately $301,627.05. This represents a 5.22% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

• Why Intuitive Surgical’s Strong Quarter Still Spooked Investors

Mark Brosius also recently made the following trade(s):

• On Wednesday, September 9th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $350.20, for a total value of $8,054.60.
• On Friday, August 21st, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89.
• On Wednesday, August 19th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $394.26, for a total transaction of $30,358.02.
• On Monday, August 17th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $390.67, for a total transaction of $30,081.59.
• On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $351.00, for a total transaction of $9,828.00.
• On Wednesday, July 29th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $360.21, for a total transaction of $10,085.88.
• On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $344.00, for a total transaction of $9,632.00.
• On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $414.13, for a total transaction of $10,353.25.

Intuitive Surgical Stock Up 0.9%

---

---

NASDAQ:ISRG opened at $353.24 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The firm has a market capitalization of $124.79 billion, a P/E ratio of 40.46, a P/E/G ratio of 2.64 and a beta of 1.47. The stock's fifty day simple moving average is $378.72 and its 200-day simple moving average is $425.22.

• Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm's revenue was up 18.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.81 earnings per share. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: A large meta-analysis found that da Vinci robotic-assisted surgery was associated with statistically significant improvements across 13 common benign conditions, including shorter hospital stays and faster returns to work versus laparoscopic and open surgery. The findings support the clinical value of Intuitive’s platform and could help drive hospital adoption. New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery
• Positive Sentiment: BTIG reaffirmed its “buy” rating and assigned a $469 price target, implying substantial upside from recent trading levels. Other analyst commentary also remains broadly favorable, although investors may be discounting some recommendations because sell-side ratings tend to be optimistic. BTIG reaffirms buy rating on Intuitive Surgical
• Positive Sentiment: Articles note that ISRG is trading at its cheapest valuation in roughly a decade. Combined with recent revenue growth of about 18% and strong earnings execution, the lower valuation is attracting interest from value-oriented investors. ISRG stock trading at its cheapest in 10 years
• Neutral Sentiment: Intuitive presented at the Wells Fargo Healthcare Conference, keeping investor attention on procedure trends, guidance, competition, and the company’s long-term robotic-surgery opportunity. Intuitive Surgical Wells Fargo Healthcare Conference transcript
• Negative Sentiment: Recent selling pressure has been linked to slower U.S. procedure growth, rising costs, competitive threats, and potential effects from GLP-1 drugs. Investors are also questioning whether the company’s earnings multiple is justified while growth moderates. Why Intuitive Surgical fell more than the broader market
• Negative Sentiment: EVP Mark Brosius reported two sales totaling 69 shares. The transactions were made under a pre-arranged Rule 10b5-1 plan and are small relative to his remaining holdings, limiting their significance; however, broader insider activity has consisted predominantly of sales rather than purchases.

Analysts Set New Price Targets

• 5 Stocks Racing Ahead as AI Supercharges Robotics

Several equities research analysts have commented on ISRG shares. Royal Bank Of Canada lowered their target price on shares of Intuitive Surgical from $650.00 to $600.00 and set an "outperform" rating for the company in a research note on Monday, July 13th. BMO Capital Markets reissued an "outperform" rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Bank of America decreased their price target on shares of Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. KeyCorp reaffirmed an "overweight" rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Finally, Piper Sandler reiterated an "overweight" rating on shares of Intuitive Surgical in a report on Friday, August 21st. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $508.68.

View Our Latest Analysis on ISRG

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Prosperity Consulting Group LLC boosted its stake in Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider's stock worth $1,804,000 after purchasing an additional 19 shares during the period. Valeo Financial Advisors LLC increased its holdings in Intuitive Surgical by 0.4% during the 4th quarter. Valeo Financial Advisors LLC now owns 4,941 shares of the medical equipment provider's stock worth $2,798,000 after purchasing an additional 21 shares in the last quarter. Dana Investment Advisors Inc. raised its stake in shares of Intuitive Surgical by 1.9% in the 4th quarter. Dana Investment Advisors Inc. now owns 1,140 shares of the medical equipment provider's stock valued at $646,000 after purchasing an additional 21 shares during the period. Forefront Wealth Partners LLC lifted its holdings in shares of Intuitive Surgical by 2.6% in the fourth quarter. Forefront Wealth Partners LLC now owns 819 shares of the medical equipment provider's stock valued at $464,000 after purchasing an additional 21 shares in the last quarter. Finally, High Note Wealth LLC boosted its position in shares of Intuitive Surgical by 50.0% during the fourth quarter. High Note Wealth LLC now owns 69 shares of the medical equipment provider's stock worth $39,000 after buying an additional 23 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company's principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.

See Also

• Five stocks we like better than Intuitive Surgical
• Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
• GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
• Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
• Sovereign AI: Palantir and Nebius Cut the Cloud Cord

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].